Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v3-EN
Language French English
Date Updated 2020-05-21 2019-11-21
Drug Identification Number 00700401 00700401
Brand name TEVA-PREDNISOLONE TEVA-PREDNISOLONE
Common or Proper name PREDNISOLONE PREDNISOLONE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients PREDNISOLONE ACETATE PREDNISOLONE ACETATE
Strength(s) 1% 1%
Dosage form(s) SUSPENSION SUSPENSION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML 5ML
ATC code S01BA S01BA
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-16 2019-10-16
Estimated end date 2020-05-31 2019-12-31
Actual end date 2020-05-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Allocating to 100% of our market.
Health Canada comments